{
    "title": "113_hr5790",
    "content": "The Act titled \"Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014\" introduces prize competitions for improving health outcomes and reducing federal expenditures under the Public Health Service Act. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 aims to improve health outcomes and reduce Federal expenditures on health programs through prize competitions. The Director of NIH will identify 3 to 5 human diseases or health conditions in consultation with relevant experts. The Rewarding Innovation, Savings, and Effectiveness Act of 2014 requires the Director of NIH, in consultation with experts, to identify 3 to 5 human diseases or health conditions with significant prevention and treatment spending for prize competitions. The Federal Government must spend at least $5 billion per year on prevention and treatment activities for identified diseases with disproportionately low research investment compared to other diseases. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 aims to address the disproportionately low research investment in certain diseases compared to others. The Director of NIH is required to design prize competitions within 12 months of the Act's enactment to achieve this goal. The Director of NIH is mandated to design prize competitions within 12 months of the Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 to cooperate with competitors for innovations in addressing specific diseases or conditions. The Director of NIH is required to design prize competitions to collaborate with competitors for innovations in addressing specific diseases or conditions, and award prizes to the most promising innovations. The Director of NIH is mandated to organize prize competitions to engage with competitors for innovative solutions to specific diseases or conditions, and award prizes to the most promising and successful innovations. The NIH organizes prize competitions to engage competitors for innovative solutions to diseases, awarding prizes to the best solutions. The design of competitions must be realistic and unbiased towards certain types of innovations. The NIH organizes prize competitions for innovative solutions to diseases, ensuring realistic and unbiased design. Competitors can participate regardless of their location or citizenship. The NIH organizes prize competitions for innovative solutions to diseases, allowing anyone to participate regardless of location or citizenship. The competitions address areas of unmet need and a report on the design is submitted to Congress. The NIH organizes prize competitions for innovative solutions to diseases, consulting with experts and relevant federal agencies. A report on the design of the competitions is submitted to Congress. The Director of NIH consults with medical, economic, budgetary, innovation, and venture capital experts, as well as heads of relevant Federal agencies, including the Commissioner of Food and Drugs, the Director of the National Science Foundation, and the Administrator of the Small Business Administration. The Director of NIH is also responsible for organizing prize competitions for innovative solutions to diseases, with a report on the design of the competitions submitted to Congress. The Director of NIH, along with various experts and agency heads, will conduct simulations of prize competitions under the Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 requires simulations of prize competitions to be conducted by the Director of NIH and experts. A report on the results of the simulation and assessment must be submitted to Congress within 4 months of awarding contracts. The Director of NIH is required to conduct simulations of prize competitions and submit a report to Congress within 4 months of awarding contracts. Adjustments to the design must be made within 21 months of the enactment of the Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014. The Director of NIH must make adjustments to the design of prize competitions within 21 months of the enactment of the Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014, based on simulation results, and submit a report to Congress. The Director of NIH will adjust the design of prize competitions based on simulation results and submit a report to Congress. Private entities will implement these competitions, as per the agreements made. The Director of NIH will partner with private entities to implement prize competitions based on designs developed earlier. Competitors must demonstrate innovation effectiveness within a 5-year period, with guidance and access to testing facilities provided by the Secretary and the Commissioner of Food and Drugs. The Director of NIH will conduct a maximum of 5 prize competitions, with up to 2 involving cooperation with the Secretary and the Commissioner of Food and Drugs for guidance and testing facilities. The Director of NIH will conduct up to 5 prize competitions, with a maximum of 2 focused on any disease or condition. The Director will track and report on the medical efficacy of funded innovations and their potential impact. The Director of NIH will collect information on the medical efficacy and impact of innovations funded through prize competitions, submitting reports to Congress annually for five years after the conclusion of the competitions. The Federal Government must not acquire intellectual property rights without the participant's written consent in prize competitions, as stated in subsection (g). A report on the collected information must be submitted to Congress annually for five years after the competitions. The Federal Government cannot acquire intellectual property rights without the participant's consent in prize competitions under subsection (g). The government may negotiate a license for the use of intellectual property developed in these competitions. Authorization of appropriations is required to implement this section. The Federal Government may negotiate a license for the use of intellectual property developed by participants in prize competitions under subsection (e). Authorization of appropriations totaling $50,000,000 is provided to carry out this section. Authorization of $50,000,000 for prize competitions under subsection (e), with a minimum of 70% of assistance awarded as prizes to competitors. The legislation specifies that not more than 30 percent of assistance for prize competitions shall be for administration, with at least 70 percent awarded as prizes to competitors. Additionally, certain prizes for improving health outcomes are excluded from gross income. The legislation excludes certain prizes for improving health outcomes from gross income under the Internal Revenue Code. The amendment applies to taxable years ending after the enactment of the Act."
}